| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.634 | 4.965 | 4.843 | 6.952 | 17.850 |
| Total Income - EUR | - | - | - | - | - | 2.634 | 4.965 | 4.845 | 6.952 | 17.850 |
| Total Expenses - EUR | - | - | - | - | - | 4.143 | 6.646 | 6.116 | 4.821 | 12.503 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -1.510 | -1.681 | -1.270 | 2.131 | 5.347 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.588 | -1.831 | -1.416 | 1.790 | 4.371 |
| Employees | - | - | - | - | - | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Lymehealth S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.539 | 695 | 416 | 1.323 | 2.524 |
| Inventories | - | - | - | - | - | 260 | 254 | 255 | 254 | 252 |
| Receivables | - | - | - | - | - | 264 | 95 | 50 | 67 | 66 |
| Cash | - | - | - | - | - | 1.016 | 345 | 111 | 1.003 | 2.205 |
| Shareholders Funds | - | - | - | - | - | -1.546 | -3.343 | -4.769 | -2.965 | 1.423 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 3.086 | 4.038 | 5.185 | 4.288 | 1.101 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Lymehealth S.r.l.